Agape ATP Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting continued net losses from continuing operations and a sharp decline in quarterly revenue.
Key Highlights
- Revenue declined sharply: The company reported revenue of $4,798 for the three months ended September 30, 2026, compared with $109,024 in the same period of 2025, according to the filing.
- Net loss from continuing operations: The company recorded a net loss from continuing operations of $83,684 for the three-month period, versus $574,013 in the prior-year quarter.
- Nine-month net loss: For the nine months ended September 30, 2026, the company reported a net loss of $275,153, compared with $1,931,535 for the same period in 2025.
- Exchange gain was significant: The filing reported an exchange gain, net, of $330,899 for the three months ended September 30, 2026, and $1,298,384 for the nine-month period, partially offsetting operating losses.
- Total assets increased: Total assets stood at $25,317,516 as of September 30, 2026, up from $24,591,278 as of December 31, 2025.
- Shares outstanding: Common stock outstanding was 1,000,626 shares as of November 13, 2026, reflecting a 1-for-50 reverse stock split effective February 20, 2026.
- Accumulated deficit: The accumulated deficit reached $12,056,136 as of September 30, 2026, compared with $11,797,836 as of December 31, 2025.
Agape ATP Corporation's Financial Position and Operating Results for Q3 2026
According to the filing, Agape ATP Corporation (NASDAQ:ATPC) reported revenue of $4,798 for the three months ended September 30, 2026, a steep drop from $109,024 in the comparable prior-year period. For the nine months ended September 30, 2026, revenue was $40,079, compared with $352,844 for the same period in 2025. The company reported a gross profit of $4,419 for the quarter and $32,482 for the nine-month period, against cost of revenue of $379 and $7,597, respectively.
Total operating expenses for the three-month period were $411,626, comprised of selling expenses of $28,895, commission of $889, and general and administrative expenses of $381,842. For the nine-month period, total operating expenses were $1,634,798. The loss from operations was $407,207 for the quarter and $1,602,316 for the nine-month period, the filing disclosed. Notably, a net exchange gain of $330,899 for the quarter and $1,298,384 for the nine months materially reduced the reported loss before income taxes, which came to $83,478 and $307,575 for the respective periods.
On the balance sheet, the filing reported total liabilities of $3,338,105 as of September 30, 2026, up from $2,165,177 at December 31, 2025, with other payable to related parties rising to $2,345,171 from $831,714. Prepayments and deposits, the largest current asset, were $25,060,354. Cash and cash equivalents were $47,538 as of September 30, 2026, down from $89,651 at December 31, 2025. The company also disclosed deferred offering costs of $93,658 as a non-current asset, which did not appear in the prior year-end balance sheet. Total stockholders' equity attributable to Agape ATP Corporation was $21,979,411.
What Was Disclosed
Agape ATP Corporation disclosed its unaudited condensed consolidated financial statements for the quarter and nine months ended September 30, 2026, showing declining revenue, continued operating losses offset partly by exchange gains, and changes in balance sheet composition including increased related-party payables and deferred offering costs.




Please wait processing your request...